Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Binge Eating Disorders

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatment Decision-making and Weight Loss Expectations for Current Obesity Treatment.

Current obesity reports·2026

Same author

Chronic thrombocytopenia as a marker for early detection of sitosterolemia.

Journal of clinical lipidology·2025

Same author

Weight Loss With Topiramate and Phentermine Combination Therapy in a Patient With Bardet-Biedl Syndrome.

JCEM case reports·2025

Same author

Statin-Induced Necrotizing Autoimmune Myopathy: Diagnosis and Treatment Approach.

JCEM case reports·2024

Same author

Long-Term Performance of Point-of-Care Hemoglobin A1c Assays.

Journal of diabetes science and technology·2016

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Treating Severe Obesity: A Medical Perspective.

Sujaytha Paknikar¹, Kalpana Muthusamy²

¹Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, 200, 1st street SW, Rochester, MN, 55905, USA.

Advances in Therapy

|June 23, 2026

Summary

Severe obesity (BMI ≥ 50 kg/m²) is rising globally, increasing cardiometabolic disease risk. Effective management requires understanding distinct patient characteristics and integrating multimodal therapies for better outcomes.

Keywords:

Anti-obesity medication BMI ≥ 50 kg/m2 Severe obesity

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

Related Experiment Videos

Last Updated: Jun 24, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

Area of Science:

Obesity and Metabolic Health

Background:

Global obesity prevalence has surged, particularly severe obesity (BMI ≥ 50 kg/m²).
Higher adiposity correlates with increased cardiometabolic disease, functional limitations, and healthcare use.
Severe obesity presents unique clinical features impacting disease risk and treatment response.

Purpose of the Study:

To review the distinct clinical characteristics of individuals with severe obesity.
To emphasize the importance of clinician knowledge for effective management.
To explore multimodal treatment approaches for optimizing outcomes in severe obesity.

Main Methods:

This is a review article.
The review focuses on severe obesity defined as BMI ≥ 50 kg/m².
The content synthesizes current understanding of severe obesity's clinical attributes and management.

Main Results:

Individuals with severe obesity have distinct clinical profiles.
Effective weight management necessitates understanding these unique attributes.
Multimodal therapeutic strategies are crucial for successful outcomes.

Conclusions:

Clinician expertise in severe obesity is vital for preventing metabolic burden progression.
Integrating various therapies is essential for managing severe obesity.
Addressing severe obesity requires a comprehensive and tailored approach.